Categories: News

Embolx Launches Sniper G3: Revolutionizing Embolization with Enhanced Efficiency, Ease of Use, and Extended Shelf Life

SUNNYVALE, Calif., July 28, 2025 /PRNewswire/ — Embolx, a leader in advanced microcatheters for targeted embolization procedures, today announced the release of its next-generation Sniper G3 Balloon Occlusion Microcatheter. This third iteration of the innovative device delivers significant enhancements, including an extended shelf life, improved ease of use, and streamlined preparation, directly addressing critical feedback from physician users.

- Advertisement -

The highly anticipated Sniper G3 features a 24-month shelf life, doubling the longevity of its predecessor. This improvement offers greater inventory flexibility for hospitals and clinics. Designed with direct input from interventional radiologists, Sniper G3 also features improved trackability and a simplified preparation process, significantly reducing pre-procedure setup time. The new prep method eliminates several steps, cutting preparation time down to less than a minute, a crucial gain in fast-paced clinical environments. This focus on user feedback underscores Embolx’s commitment to developing intuitive, high-performance tools that enhance clinical workflow.

- Advertisement -

Sniper G3 truly exemplifies our dedication to innovation driven by physician needs,” said Michael Allen, President and CEO of Embolx. “We listened intently to our users and engineered a device that not only extends product longevity and improves performance, but also significantly enhances the ease of use, which translates directly to more efficient procedures. We are incredibly proud of Sniper G3 and its potential to set a new standard in embolization therapy.”

- Advertisement -

The Sniper G3 Balloon Occlusion Microcatheter represents a significant leap forward in Embolx’s commitment to physician-centric innovation. It is available in all standard lengths and is ready for worldwide distribution.

- Advertisement -

About Embolx
Embolx has pioneered advanced pressure-mediated delivery of therapeutics directly into cancerous tumors, prostates, and other anatomical structures and is dedicated to transforming healthcare through the development of innovative technologies.

- Advertisement -

For media inquiries, please contact:

- Advertisement -

Haley McGregor
Global Marketing and Sales Operations Manager
hmcgregor@embolx.com

- Advertisement -

Logo – https://mma.prnewswire.com/media/2738641/Sniper_g3_Logo.jpg 

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/embolx-launches-sniper-g3-revolutionizing-embolization-with-enhanced-efficiency-ease-of-use-and-extended-shelf-life-302514310.html

- Advertisement -

Recent Posts

Joveos 2026 Recruiting Benchmarks Report Reveals Up to 9x Growth in Applicant Volume Over the Past Three Years

MENLO PARK, Calif., Feb. 06, 2026 (GLOBE NEWSWIRE) -- Joveo, the global leader in AI-led,…

6 hours ago

BitMart Card Expands Global Reach to 115+ Countries, Unveils 2026 Benefits With Up to 5.5% Cashback and $300+ in Annual Rewards

MAHE, Seychelles, Feb. 06, 2026 (GLOBE NEWSWIRE) -- BitMart, a global cryptocurrency trading platform, today…

6 hours ago

Inspired Entertainment Launches Game-Changing Lottery Platform STRATA

A Fully Cloud-Made Solution on Google Cloud February 06, 2026 09:23 ET  | Source: Inspired…

6 hours ago

Skywork Launches Desktop AI Agent for Windows Productivity

Singapore, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Skywork recently announced the launch of Skywork Desktop,…

6 hours ago

Tai Software and OpenTrack Announce Integration Bringing AI-Native End-to-End Container Visibility Directly into Tai TMS

HUNTINGTON BEACH, Calif., Feb. 06, 2026 (GLOBE NEWSWIRE) -- Tai Software, a leading transportation management…

6 hours ago

Intent IQ integrates identity-driven performance at scale in Horizon Media’s newly launched HorizonOS

NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Intent IQ, a leader in next-generation identity…

6 hours ago